National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A03CA02	LIBROCOL	G	Chlordiazepoxide - 5mg, Clidinium bromide - 2.5mg		Tablet	338,648 L.L
B01AB01	HEPARINE SODIQUE PANPHARMA	G	Heparin sodium - 25,000IU/5ml	25,000IU/5ml	Injectable solution	6,134,641 L.L
B05BA10	SMOFKABIVEN	G	Glucose monohydrate - 462mg, Soya-bean oil, refined - 60mg, Triglycerides, Medium Chain - 60mg, Olive oil, refined - 50mg, Fish oil, rich in omega-3-acids - 30mg, Alanine - 14mg, Arginine - 12mg, Proline - 11.2mg, Glycine - 11mg, Lysine acetate - 9.3mg, Leucine - 7.4mg, Serine - 6.5mg, Valine - 6.2mg, Sodium acetate, 3H2O - 5.62mg, Phenylalanine - 5.1mg, Isoleucine - 5mg, Potassium chloride - 4.48mg, Threonine - 4.4mg, Methionine - 4.3mg, Sodium glycerophosphate, anhydrous - 4.18mg, Histidine - 3mg, Magnesium sulfate, 7H2O - 2.47mg, Tryptophan - 2mg, Taurine - 1mg, Calcium chloride 2H2O - 0.74mg, Tyrosine - 0.40mg, Zinc sulfate heptahydrate - 23mcg		Injectable emulsion	3,835,326 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	163,184 L.L
C09DB01	AMLODIPINE/VALSARTAN ARROW	G	Amlodipine (besylate) - 5mg, Valsartan - 160mg		Tablet, coated	923,220 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Cream	499,142 L.L
G02AX	GYNOCIN	G	Oxytocin - 5IU/0.5ml	5IU/0.5ml	Injectable concentrate for solution	313,115 L.L
H02AB04	NEPHARED	G	Methylprednisolone sodium succinate - 125mg	125mg	Injectable powder for solution	469,001 L.L
J01DD08	CEFIX	G	Cefixime (trihydrate) - 400mg	400mg	Capsule	791,523 L.L
J02AC03	VORICONAZOLE STRAGEN	G	Voriconazole - 50mg	50mg	Tablet, coated	15,808,184 L.L
L04AX03	EBETREXAT	G	Methotrexate - 15mg/1.5ml	15mg/1.5ml	Injectable solution	2,135,366 L.L
M03BX04	STIFFANO	G	Tolperisone - 150mg	150mg	Tablet	651,764 L.L
N02CC03	ZOLMITRIPTAN ARROW GENERIGUES	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, film coated	857,372 L.L
N05AL07	DISLEP	G	Levosulpiride - 25mg	25mg	Tablet	1,690,682 L.L
N06DX01	EXENTA	G	Memantine HCl - 10mg	10mg	Tablet, film coated	1,057,156 L.L
R03DC03	LEUKOTRIS	G	Montelukast - 4mg	4mg	Tablet	783,268 L.L
S01GA04	ALERJON	G	Oxymetazoline HCl -		Drops solution	528,130 L.L
A03CA02	PRIMAX	G	Clidinium bromide - 2.5mg, Chlordiazepoxide - 5mg		Tablet	222,694 L.L
A10BB09	LOWZID XR	G	Gliclazide - 60mg	60mg	Tablet, extended release	309,724 L.L
B05BA10	SMOFKABIVEN PERIPHERAL	G	Glucose monohydrate - 143mg, Soya-bean oil, refined - 60mg, Triglycerides, Medium Chain - 60mg, Olive oil, refined - 50mg, Fish oil, rich in omega-3-acids - 30mg, Alanine - 14mg, Arginine - 12mg, Proline - 11.2mg, Glycine - 11mg, Lysine acetate - 9.3mg, Leucine - 7.4mg, Serine - 6.5mg, Valine - 6.2mg, Sodium acetate, 3H2O - 5.62mg, Phenylalanine - 5.1mg, Isoleucine - 5mg, Potassium chloride - 4.48mg, Threonine - 4.4mg, Methionine - 4.3mg, Sodium glycerophosphate, anhydrous - 4.18mg, Histidine - 3mg, Magnesium sulfate, 7H2O - 2.47mg, Tryptophan - 2mg, Taurine - 1mg, Calcium chloride 2H2O - 0.74mg, Tyrosine - 0.40mg, Zinc sulfate heptahydrate - 23mcg		Injectable emulsion	4,571,752 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	176,974 L.L
C07BB03	ATONIUM PLUS	G	Chlortalidone - 25mg, Atenolol - 100mg		Tablet	738,473 L.L
C09DB01	ARBITEN AM 5/160	G	Amlodipine - 5mg, Valsartan - 160mg		Caplet, film coated	857,372 L.L
D01AE15	TERMINUS	G	Terbinafine HCl - 1%	1%	Cream	747,176 L.L
H02AB04	METHYL PREDNISOLONE VIATRIS 120MG	G	Methylprednisolone (hemisuccinate) - 120mg	120mg	Injectable dry powder for solution	579,584 L.L
J01DD08	FIXIM	G	Cefixime (trihydrate) - 400mg	400mg	Capsule	1,435,224 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 15mg/0.3ml	15mg/0.3ml	Injectable solution	1,968,729 L.L
M03BX08	JAMP-CYCLOBENZAPRINE	G	Cyclobenzaprine HCl - 10mg	10mg	Tablet	4,031,528 L.L
N02CC03	ZOLMITRIPTAN BIOGARAN	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, orodispersible	921,876 L.L
N05AN01	MANICARB SR-400	G	Lithium carbonate - 400mg	400mg	Tablet, prolonged release	1,431,192 L.L

National Cancer Registry (NCR)